Compared to Estimates, Heron Therapeutics (HRTX) Q1 Earnings: A Look at Key Metrics

For the quarter ended March 2025, Heron Therapeutics (HRTX) reported revenue of $38.9 million, up 12.2% over the same period last year. EPS came in at$ 0.01, compared to - $0.02 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of$ 37.08 million, representing a surprise of +4.93%. The company delivered an EPS surprise of +200.00%, with the consensus EPS estimate being -$0.01.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wa ...